Skip to main content

S. 1455

Introduced

TREAT Act

Introduced 5/22/2015•114th Congress•Senate

Latest Action

Placed on Senate Legislative Calendar under General Orders. Calendar No. 441.

4/27/2016 • Senate

Summary

Recovery Enhancement for Addiction Treatment Act or the TREAT Act

(Sec. 2) This bill amends the Controlled Substances Act to revise the requirements for a practitioner to administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program.

Currently, a practitioner must notify the Department of Health and Human Services and certify that he or she is a qualifying physician (i.e., a state-licensed physician with certain expertise), has the capacity to refer patients for appropriate counseling and ancillary services, and will comply with a patient limit. The patient limit is how many patients the practitioner can treat under the office-based treatment program at one time.

This bill expands qualifying practitioners to include licensed nurse practitioners and physician assistants who have expertise and prescribe medications for opioid use disorder in collaboration with or under the supervision of a qualifying physician, if required by state law.

It increases the maximum patient limit for a qualifying practitioner and requires compliance with recordkeeping requirements.

(Sec. 4) The amendments made by this bill do not preempt a state law that modifies the patient limit or requires a qualifying practitioner to comply with additional requirements.

(Sec. 5) DOJ must update regulations with respect to waived practitioners to include nurse practitioners and physician assistants.

(Sec. 6) The Government Accountability Office must evaluate the effectiveness of this bill.

Reported to Senate with amendment(s) • 4/27/2016

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Congressional oversightDrug therapyDrug trafficking and controlled substancesDrug, alcohol, tobacco useGovernment studies and investigationsHealth facilities and institutionsHealth personnelPrescription drugs

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (21)

Party Breakdown

16
Democrats
3
Republicans
2
Independents

Sponsor

S[
Sen. Markey, Edward J. [D-MA]

Democrat • MA

Sponsored 5/22/2015

Cosponsors (20)

S[
Sen. Paul, Rand [R-KY]

R-KY

Joined 5/22/2015

S[
Sen. Feinstein, Dianne [D-CA]

D-CA

Joined 5/22/2015

S[
Sen. Durbin, Richard J. [D-IL]

D-IL

Joined 5/22/2015

S[
Sen. Hirono, Mazie K. [D-HI]

D-HI

Joined 5/22/2015

S[
Sen. Brown, Sherrod [D-OH]

D-OH

Joined 5/22/2015

S[
Sen. Baldwin, Tammy [D-WI]

D-WI

Joined 5/22/2015

Bill Journey

Originated in the Senate

Introduced

May 22, 2015

Committee Review

March 16, 2016

Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (2)

Reported to Senate4/27/2016
Introduced in Senate5/22/2015

Details

Bill TypeS
Current StatusIntroduced
Cosponsors20